Italy In-Vitro Diagnostics Market Forecast Report by Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, Others) Products (Services, Instruments, Reagents) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Haematology, Microbiology, Coagulation, Others) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) End User (Hospitals, Laboratories, Home - Care, Others) and Company Analysis, 2024-2032
Buy NowItaly In-Vitro Diagnostics Market Analysis
Italy In-Vitro Diagnostics Market was US$ 2.61 Billion in 2023 and will grow US$ 4.67 Billion by 2032, with a CAGR of 6.68% from 2024 to 2032. Growth is also anticipated to be fueled by the nation's growing chronic disease prevalence and the significant investments made in R&D by industry leaders to create cutting-edge technologies for investigating novel approaches to disease detection. Italy is predicted to see a rise in the prevalence of a number of diseases, including cancer, autoimmune disorders, myocardial infarctions, arrhythmias, and inflammatory ailments, which will drive up demand for IVD testing.
Italy In-Vitro Diagnostics Market Overview
The term "in-vitro diagnostics" (IVD) describes a broad range of medical procedures used to diagnose illnesses, track the effectiveness of treatment, and evaluate general health status using samples of human fluids, tissues, or cells that are kept outside of the body. Numerous methods and tools, such as immunoassays, molecular diagnostics, clinical chemistry, hematology, and microbiology, are used to conduct these tests in laboratory settings. These tests make it possible to identify illnesses early, which enables prompt intervention and the start of therapy. IVD testing provide personalized medicine by facilitating quick and precise results that inform customized treatment plans based on unique patient features. Additionally, by offering insightful knowledge about biological systems, in-vitro trials help researchers and scientists advance areas like pharmacology, biotechnology, and medicine. They are vital resources for comprehending basic biological processes and creating novel approaches to health problems.
The increasing occurrence of chronic illnesses is a major driver propelling the market's expansion. The need for early diagnosis utilizing IVD devices is rising due to the number of patients with various infectious and chronic diseases. As a result, more people are using in-vitro diagnostics for a variety of ailments. For example, a December 2022 report published by Nova Agency indicated that 390,700 new cases of cancer were expected in Italy year 2022. In a similar vein, the International Diabetes Federation (IDF) estimates that 4.47 million Italians suffered from diabetes in 2021 and that number is expected to rise to 4.59 million by 2045. As a result, the high prevalence of disease among Italians is fueling the nation's adoption of in-vitro diagnostic instruments and raising the demand for early disease diagnosis.
| Report Features | Details |
|
Base Year |
2023 |
|
Forecast Years |
2024 - 2032 |
|
Historical Years |
2019 - 2023 |
|
Market Size in 2023 |
US$ 2.61 Billion |
|
Market Forecast in 2032 |
US$ 4.67 Billion |
|
Market Growth Rate (2024-2032) |
6.68% |
Growth Factors in the Italy In-Vitro Diagnostics Industry
Growth in the In-Vitro Diagnostics Market is Driven by Increasing Healthcare Spending in Italy
The in-vitro diagnostics business in Italy is expanding thanks in large part to the notable rise in healthcare spending. Italy has made large investments in healthcare, amounting to USD 4291 per capita and accounting for 9.0% of its GDP, as per an OECD assessment. This indicates a strong commitment to improving healthcare infrastructure and services. This large donation encourages advancements in patient care delivery by enabling healthcare providers to use cutting-edge diagnostic tools and creative solutions.
Information and Communications Technology (ICT) Integration in Healthcare Fuels Market Expansion
The growing in-vitro diagnostics business in Italy is mostly being driven by the integration of Information and Communications Technology (ICT) in healthcare. With a 7% rise from 2021 to 2022, Italy spent USD 1.98 billion on ICT for healthcare. Healthcare diagnostic processes can be made more accurate and efficient by leveraging digital tools like data analytics, telemedicine platforms, and electronic health records. ICT facilitates easy communication between labs, medical professionals, and patients, allowing for the early diagnosis of illnesses and the modification of treatment plans as necessary. ICT developments also make it possible to remotely monitor patients' health problems, which allows for quick intervention and the application of preventive healthcare measures.
Italy In-Vitro Diagnostics Market Company Overview
Some of the industry leaders seen in the Italy In-Vitro Diagnostics Market Includes Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation.
Italy In-Vitro Diagnostics Market News
In April 2023, in order to commercialize the DiviTum TKa test in Italy, Biovica International and IT Health Fusion entered into a business cooperation. Thymidine kinase activity (TKa) in human serum is measured semi-quantitatively using this in-vitro diagnostic instrument.
In May 2022, Italy implemented the new EU In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR) on May 26, 2022. While some legacy devices will benefit from transitional periods, the IVDR criteria now apply to all new IVDs as well as those low-risk IVDs that are already marketed.
Test Types – Market breakup in 11 viewpoints:
- ELISA & CLIA
- PCR
- Rapid Test
- Fluorescence Immunoassays (FIA)
- In Situ Hybridization
- Transcription Mediated Amplification
- Sequencing
- Colorimetric Immunoassay
- Radioimmunoassay (RIA)
- Isothermal Nucleic Acid Amplification Technology
- Others
Products – Market breakup in 3 viewpoints:
- Services
- Instruments
- Reagents
Technology – Market breakup in 7 viewpoints:
- Immunoassay
- Clinical Chemistry
- Molecular Diagnostics/Genetics
- Hematology
- Microbiology
- Coagulation
- Others
Application – Market breakup in 8 viewpoints:
- Infectious Disease
- Diabetes
- Cardiology
- Oncology
- Nephrology
- Autoimmune Diseases
- Drug Testing
- Other Applications
End User – Market breakup in 4 viewpoints:
- Hospitals
- Laboratories
- Home - Care
- Others
All the Key players have been covered from 5 Viewpoints:
- Overviews
- Key Person
- Recent Developments & Strategies
- Product Portfolio & Product Launch in Last 1 Year
- Revenue
Company Analysis:
- Roche Diagnostics
- Abbott Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Sysmex Corporation
Report Details:
| Report Features | Details |
| Base Year |
2023 |
| Historical Period |
2019 - 2023 |
| Forecast Period |
2024 - 2032 |
| Market |
US$ Billion |
| Segment Covered |
Test Type, Products Type, Technology, Application, and End User |
| Test Types Covered |
|
| Companies Covered |
|
| Customization Scope |
20% Free Customization |
| Post-Sale Analyst Support |
1 Year (52 Weeks) |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Key Questions Answered in This Report:
- How big is the Italy In-Vitro Diagnostics industry?
- What is the Italy In-Vitro Diagnostics industry growth rate?
- Who are the key players in Italy In-Vitro Diagnostics industry?
- What are the factors driving the Italy In-Vitro Diagnostics industry?
- Which Region held the largest market share in the Italy In-Vitro Diagnostics industry?
- What segments are covered in the Italy In-Vitro Diagnostics Market report?
Customization Services available
- Analysis of Market Size and Its Segments
- More Company Profiles (Upto 10 without any additional cost):
- Additional Countries (Other than mentioned Countries):
- Region/Country Specific Reports:
- Market Entry Strategy:
- Region-Specific Market Dynamics:
- Regional Market Share Analysis:
- Trade Analysis:
- Production Insights:
- Others Customized Requests:
For more information contact our analysts.
Need More Assistance?
- Talk to our analysts to get more precious information on the current market trends.
- Include more countries and segments and customize the report based on the final requirement.
- Get a competitive advantage in your industry by knowing the report findings and making a positive impact on your revenues and operations.
- Our analysts are always ready to provide more help and pertinent information if you need any additional assistance.
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamic
4.1 Growth Drivers
4.2 Challenges
5. Italy In-Vitro Diagnostics (IVD) Market
6. Market Share
6.1 By Test Types
6.2 By Products
6.3 By Technology
6.4 By Application
6.5 By End User
7. By Test Types
7.1 ELISA & CLIA
7.2 PCR
7.3 Rapid Test
7.4 Fluorescence Immunoassays (FIA)
7.5 In Situ Hybridization
7.6 Transcription Mediated Amplification
7.7 Sequencing
7.8 Colorimetric Immunoassay
7.9 Radioimmunoassay (RIA)
7.10 Isothermal Nucleic Acid Amplification Technology
7.11 Others
8. By Products
8.1 Services
8.2 Instruments
8.3 Reagents
9. By Technology
9.1 Immunoassay
9.2 Clinical Chemistry
9.3 Molecular Diagnostics/Genetics
9.4 Hematology
9.5 Microbiology
9.6 Coagulation
9.7 Others
10. By Application
10.1 Infectious Disease
10.2 Diabetes
10.3 Cardiology
10.4 Oncology
10.5 Nephrology
10.6 Autoimmune Diseases
10.7 Drug Testing
10.8 Other Applications
11. By End User
11.1 Hospitals
11.2 Laboratories
11.3 Home - Care
11.4 Others
12. Porter’s Five Forces
12.1 Bargaining Power of Buyer
12.2 Bargaining Power of Supplier
12.3 Threat of New Entrants
12.4 Rivalry among Existing Competitors
12.5 Threat of Substitute Products
13. SWOT Analysis
13.1 Strengths
13.2 Weaknesses
13.3 Opportunities
13.4 Threats
14. Government Rules & Regulation
15. Reimbursement
15.1 Public
15.2 Private & Insurance
16. Key Players Analysis
16.1 Roche Diagnostics
16.1.1 Overviews
16.1.2 Key Person
16.1.3 Recent Development
16.1.4 Product Portfolio & Product Launch in Last 1 Year
16.1.5 Revenue
16.2 Abbott Diagnostics
16.2.1 Overviews
16.2.2 Key Person
16.2.3 Recent Development
16.2.4 Product Portfolio & Product Launch in Last 1 Year
16.2.5 Revenue
16.3 Siemens Healthineers
16.3.1 Overviews
16.3.2 Key Person
16.3.3 Recent Development
16.3.4 Product Portfolio & Product Launch in Last 1 Year
16.3.5 Revenue
16.4 Danaher Corporation
16.4.1 Overviews
16.4.2 Key Person
16.4.3 Recent Development
16.4.4 Product Portfolio & Product Launch in Last 1 Year
16.4.5 Revenue
16.5 Thermo Fisher Scientific
16.5.1 Overviews
16.5.2 Key Person
16.5.3 Recent Development
16.5.4 Product Portfolio & Product Launch in Last 1 Year
16.5.5 Revenue
16.6 Sysmex Corporation
16.6.1 Overviews
16.6.2 Key Person
16.6.3 Recent Development
16.6.4 Product Portfolio & Product Launch in Last 1 Year
16.6.5 Revenue
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com